Key Findings:  The results indicate that anandamide-mediated signaling at CB1 receptors, driven by oxytocin, controls social reward. Deficits in this signaling mechanism may contribute to social impairment in autism spectrum disorders and might offer an avenue to treat these conditions.
Type of Study:  Animal Study
Study Result:  Positive
Study Location(s):  Spain, United States
Year of Pub:  2015
Cannabinoids Studied:  Anandamide (AEA)
Phytocannabinoid Source:  Not Applicable
Receptors Studied:  CB1
Ligands Studied:  Oxytocin